首页> 外国专利> Concentrated and expanded human umbilical cord blood stem cells for treating hematologic diseases

Concentrated and expanded human umbilical cord blood stem cells for treating hematologic diseases

机译:浓缩和扩增的人类脐带血干细胞用于治疗血液系统疾病

摘要

This invention relates to an enriched population of isolated and expanded human cord blood stem cells and a method of producing an enriched population of isolated and expanded human cord blood stem cells. The expanded human cord blood stem cells are CD34+, CD90+, CD1 84+, CD1 17+, CD49f+, ALDH+, CD45RA and express pluripotency genes SOX2, OCT4, NANOG, and ZIC3. In one embodiment, the stem cells in the enriched population of the present invention are positive for aldehyde dehydrogenase activity (ALDH+). In addition, in one embodiment the expanded stem cells are nearly depleted of T cells and B cells and contain a limited number of monocytes (CD14). Also disclosed is a method of treating a subject for a hematological disorder using the stem cells of the present invention and a method of determining the effects of a compound on hematopoietic stem cells.
机译:本发明涉及分离和扩增的人脐带血干细胞的富集群体,以及生产分离和扩增的人脐带血干细胞的富集群体的方法。扩增的人脐带血干细胞为CD34 +,CD90 +,CD1 84 +,CD1 17 +,CD49f +,ALDH +,CD45RA,并表达多能性基因SOX2,OCT4,NANOG和ZIC3。在一实施方案中,本发明富集群体中的干细胞醛脱氢酶活性(ALDH +)呈阳性。另外,在一个实施方案中,扩增的干细胞几乎耗尽了T细胞和B细胞,并且包含有限数量的单核细胞(CD14)。还公开了使用本发明的干细胞治疗对象的血液病的方法,以及确定化合物对造血干细胞的作用的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号